* If you want to update the article please login/register
"Blood tumors are characterized by pathologic disorders that result in uncontrolled hemmatological cell division. " However, all these drugs have serious drawbacks that limit their use in blood cancer therapy, such as inadequate metabolism. Natural killer cells are isolated and purified during Car-T cell therapy, which is a significant challenge. For blood cancer treatments, treatment methods from phyto-medicine scaffolds have been evaluated to cope with these challenges. Carotenoids, a versatile class of phytochemical with therapeutic value in cancer therapy, and particularly blood cancer. This review article explores carotenoids' therapeutic potential in blood cancers, focusing on various mechanisms and signaling pathways that mediate their therapeutic efficiency. ".
Source link: https://doi.org/10.3390/nu14091949
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions